Quantum Computing, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a QUBT research report →
Range $10 – $22
Price Chart
About the company
Quantum Computing, Inc. (QUBT) is a Virginia-based technology firm dedicated to developing advanced software solutions for quantum computing. A cornerstone of their offerings is Qatalyst, a quantum application accelerator designed to empower developers.
- CEO
- Yuping Huang
- IPO
- 2007
- Employees
- 75
- HQ
- Hoboken, NJ, US
AI snapshot
Six angles, distilled from the data.
The stock is in a volatile recovery phase after a deep reset from its 52-week high of 23.875, but it still trades below the 200-day moving average of 9.1978. The 50-day average at 8.4187 sits just under the current regime, suggesting a short-term rebound inside a longer-term repair process.
Street sentiment is constructive but not euphoric: consensus sits at Buy with 3 buys and 1 hold. The target stack has softened from earlier highs, with a consensus target of 17.33 versus a 20 median and a 10-22 range, while recent calls were mixed between Buy and Neutral.
The earnings profile is uneven but improving on select quarters, with 4 beats in the last 7 reports and the most recent quarter matching estimates. Next-quarter EPS is expected at -0.07, while full-year 2027 EPS estimates remain negative, so shareholders should watch for margin discipline and whether revenue growth can outpace losses.
No notable discretionary insider buying or selling. Recent filings are dominated by award and vesting-related transactions for the CEO and other officers, which read as compensation flows rather than conviction trades.
Profitability remains weak, but top-line growth is strong. Revenue growth was 90% year over year, yet gross margin was -18.9%, operating margin -2.8127, and net margin -1.5245, showing the business is still scaling through losses.
QUBT sits in a speculative quantum and photonics niche rather than a mature hardware peer set, so valuation is driven more by execution than current earnings power. At 8.545, it trades on a negative P/E and remains a story stock versus the broader technology hardware group.
Similar companies
Peers in the same neighborhood.
- Market Cap
- $1.76B
- P/E
- -121.48
- Fwd P/E
- 15.12
- PEG
- 0.65
- P/S
- 179.65
- P/B
- 1.11
- EV/EBITDA
- -245.64
- Div Yield
- 0.00%
- Gross Margin
- -18.92%
- Op Margin
- -775.48%
- Net Margin
- -152.45%
- ROE
- -1.06%
- ROIC
- -4.69%
Latest fiscal year · YoY change
- Revenue
- $682.00K+82.8%
- Gross Profit
- $67.00K-40.2%
- Op Income
- $-51,077,000
- Net Income
- $-18,674,000+72.8%
- EPS
- $-0.11+84.9%
- OCF Growth
- -86.9%
- FCF Growth
- -66.2%
- 52W High
- $23.88
- 52W Low
- $6.18
- 50D MA
- $8.44
- 200D MA
- $9.17
- Beta
- 3.77
- RSI (14)
- 39
- Avg Volume
- 7.82M
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Quantum Computing Inc. said Q2 reflected rapid growth in revenue and commercial activity, driven by acquisitions, new customer wins, and continued investment in photonic and quantum manufacturing.· August 10, 2026
- Q2 revenue was $5.6 million, up from $61 thousand a year ago and up from $3.7 million in Q1.
- Net loss narrowed to $11.8 million, or $0.05 per share, versus a $36.5 million loss, or $0.26 per share, last year.
- Cash, cash equivalents and investments were about $1.3 billion at June 30, with total assets around $1.6 billion.
- Management said backlog was about $42.5 million and described it as work to be performed over 12 to 18 months.
- The company highlighted three acquisitions, a new Dirac-3 installation, a $10 million-plus potential Neurawave program, and an increased push into government and commercial sales.
Revenue for Q2 2026 totaled $5.6 million, compared with $61 thousand in Q2 2025 and $3.7 million in Q1 2026. Operating expenses were $21.8 million versus $10.2 million a year ago, with about $7.3 million of acquisition-related transaction expenses. Net loss was $11.8 million, or $0.05 per share, versus a net loss of $36.5 million, or $0.26 per basic share, in the prior-year period. Interest and other income was $13 million versus $1.8 million last year, helped by a larger cash position. Total assets were about $1.6 billion, cash/cash equivalents/investments were about $1.3 billion, liabilities were $47.2 million, and backlog was about $42.5 million. For forward commentary, management did not give formal quarterly revenue guidance; it said the company expects the business mix to remain lumpy, that backlog could support operations into third quarter of next year if no new business came in, and that QCI still stands by prior views that Enhanced could contribute somewhere between about $7.07 million and $16 million, while the company’s overall model had previously pointed to $20 million to $25 million for this year.
Yuping Huang emphasized that QCI is trying to turn its quantum roadmap into a broader commercial platform built on nanophotonics, advanced packaging, and U.S.-based semiconductor manufacturing. He framed the company’s goal as making quantum systems smaller, more practical, and more accessible, while also monetizing photonic products and services today. His tone was upbeat and confident, especially around Dirac-3 progress, the Neurawave commercialization milestone, and the idea that the company is reaching an inflection point for larger-scale market adoption.
Christopher Bruce Roberts focused on the quarter’s financial expansion and balance sheet strength. He cited Q2 revenue of $5.6 million, operating expenses of $21.8 million, and a net loss of $11.8 million, noting that the year-over-year loss improvement was largely driven by a smaller noncash derivative liability mark-to-market loss of $1.7 million versus $28 million last year. He said cash, cash equivalents and investments were about $1.3 billion, down from about $1.5 billion at year-end after roughly $180 million of cash used for acquisitions including Luminar Semiconductor, NuCrypt, and Enhanced Semiconductor, and he said upgrading the Enhanced facility could require roughly $50 million to $100 million, with about $75 million as a working estimate, though not this year.
Analysts focused on Dirac-3 functionality, backlog durability, end-market mix, and the financial impact of the Enhanced acquisition. Management said Dirac-3 has made progress on adding more variables and hinted at news in the coming month, while also explaining that the system is aimed at NP-hard optimization problems using room-temperature photonics rather than a quantum annealer. On backlog, management said the $42.5 million figure is not likely to be burned down quickly because the contracts run 12 to 18 months; on customers, they said government contracting currently accounts for roughly 70% to 80% of the business, mainly as a subcontractor, though commercial interest is rising. They also said the company is expanding sales coverage by hiring a new chief revenue officer and adding sales talent.
The call showed real revenue traction, with Q2 revenue up sharply year over year and sequentially, plus a much larger backlog than in prior periods. Management pointed to multiple commercial and technical catalysts: a Dirac-3 installation, Neurawave commercial readiness, a framework agreement that could exceed $10 million, and a very large cash position that supports acquisitions and manufacturing investment.
The business is still lumpy, heavily dependent on government subcontracting, and management repeatedly avoided formal guidance. They also acknowledged that scaling the Enhanced facility could require significant additional capital, that some projects and Navy-related funding have slipped, and that the commercial mix may take time to shift away from government work.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 89.3%
- Shares Outstanding
- 224.54M
- Float Shares
- 200.41M
of shares held by institutions
345 13F filers
Buy/sell ratio 1.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Blackrock, Inc. | 17.73M | ▲ 1.59M |
| Vanguard Group Inc | 16.84M | ▲ 4.64M |
| Vanguard Capital Management LLC | 8.85M | ▲ 86.59K |
| Defiance Etfs, LLC | 7.03M | ▲ 2.54M |
| Penserra Capital Management LLC | 6.98M | ▲ 3.63M |
| Vanguard Portfolio Management LLC | 6.57M | ▼ 143.54K |
| Geode Capital Management, LLC | 5.32M | ▲ 622.34K |
| State Street Corp | 4.92M | ▲ 404.50K |
| Morgan Stanley | 3.29M | ▲ 971.28K |
| Marex Group PLC | 2.30M | ▼ 2.19M |
| Mirae Asset Global Etfs Holdings Ltd. | 2.27M | ▲ 69.23K |
| Ubs Group AG | 2.05M | ▲ 729.51K |
Held by 260 ETFs
Biggest fund positions in QUBT by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Aug 20, 26 | Huang Yuping | other | 584,897 |
| Aug 20, 26 | Huang Yuping | other | 584,897 |
| Aug 20, 26 | Huang Yuping | other | 584,897 |
| Aug 20, 26 | Huang Yuping | other | 584,897 |
| Jul 17, 26 | Hunt Susan G. | other | 0 |
| May 28, 26 | Huang Yuping | other | 58,558 |
| May 28, 26 | Huang Yuping | other | 23,588 |
| May 28, 26 | Dianat Pouya | other | 9,979 |
| May 28, 26 | Dianat Pouya | other | 24,774 |
| May 28, 26 | Begliarbekov Milan | other | 9,979 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our QUBT coverage
Recent articles, reports, and earnings notes.

Pasqal Holding S.A. IPO: The Bull Case Meets the Quantum Risk
Pasqal Holding S.A. is expected to list on Nasdaq on August 28, 2026 under PSQL, but the price range has not been disclosed. The setup pits fast revenue growth and a large quantum-computing opportunity against heavy losses, execution risk, and a still-early market.

Inside the Pasqal Holding SA IPO: Setup, Risks, and Verdict
Pasqal Holding SA Ordinary Share is expected to list on NASDAQ on 2026-08-28 under ticker PSQL. The company has not disclosed a price range or share count yet. The setup leans on real commercial traction, but investors should watch valuation, dilution, and whether quantum demand can keep scaling.

TF3 Revolution, Revealed: What Stock Is Marc Lichtenfeld Teasing in The Oxford Income Letter?
Marc Lichtenfeld and The Oxford Club's The Oxford Income Letter are pitching the "TF3 Revolution"; here's the company behind the $20 stock claim and what the filings support.
Want a deeper read on QUBT?
Generate a full analyst-grade report — bull/bear case, price targets, valuation depth, and a complete financial breakdown.
Quantum Computing Inc. to Attend the Maxim Growth Summit 2026
prnewswire.com · Oct 6
Reviewing Apple (NASDAQ:AAPL) & Quantum Computing (NASDAQ:QUBT)
defenseworld.net · Oct 4
Is Quantum Computing Inc. a Buy Right Now?
fool.com · Oct 1
Quantum Computing Inc. Announces Dirac-3S, Scaling to Nearly 10,000 Variables
prnewswire.com · Oct 1
Financial Survey: Quantum Computing (NASDAQ:QUBT) vs. Foxx Development (NASDAQ:FOXX)
defenseworld.net · Sep 29
RGTI vs QUBT: Which Quantum Computing Stock Has More Upside Potential?
zacks.com · Sep 28
Kuehn Law Encourages Investors of Quantum Computing Inc. to Contact Law Firm
prnewswire.com · Sep 28
QUBT vs. IONQ: Which Quantum Stock Should You Buy, Hold or Sell Now?
zacks.com · Sep 25
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.
AI analysis · Last refreshed October 2, 2026 · Live quote · Not investment advice